The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
Open accessAbstract
Vascular endothelial growth factor A (VEGFA; hereafter referred to as VEGF) is a key regulator of physiological and pathological angiogenesis. Two families of VEGF isoforms are generated by alternate splice-site selection in the terminal exon. Proximal splice-site selection (PSS) in exon 8 results in pro-angiogenic VEGFxxx isoforms (xxx is the number of amino acids), whereas distal splice-site selection (DSS) results in anti-angiogenic VEGFxxxb isoforms. To investigate control of PSS and DSS, we investigated the regulation of isoform expression by extracellular growth factor administration and intracellular splicing factors. In primary epithelial cells VEGFxxxb formed the majority of VEGF isoforms (74%). IGF1, and TNFα treatment favoured PSS (increasing VEGFxxx) whereas TGFβ1 favoured DSS, increasing VEGFxxxb levels. TGFβ1 induced DSS selection was prevented by inhibition of p38 MAPK and the Clk/sty (CDC-like kinase, CLK1) splicing factor kinase family, but not ERK1/2. Clk phosphorylates SR protein splicing factors ASF/SF2, SRp40 and SRp55. To determine whether SR splicing factors alter VEGF splicing, they were overexpressed in epithelial cells, and VEGF isoform production assessed. ASF/SF2, and SRp40 both favoured PSS, whereas SRp55 upregulated VEGFxxxb (DSS) isoforms relative to VEGFxxx. SRp55 knockdown reduced expression of VEGF165b. Moreover, SRp55 bound to a 35 nucleotide region of the 3′UTR immediately downstream of the stop codon in exon 8b. These results identify regulation of splicing by growth and splice factors as a key event in determining the relative pro-versus anti-angiogenic expression of VEGF isoforms, and suggest that p38 MAPK-Clk/sty kinases are responsible for the TGFβ1-induced DSS selection, and identify SRp55 as a key regulatory splice factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., & Leung, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1806 · Cited by 1,365
Understanding alternative splicing: towards a cellular code
Matlin, A. J., Clark, F., & Smith, C. W. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1645 · Cited by 1,305
A Conditionally Immortalized Human Podocyte Cell Line Demonstrating Nephrin and Podocin Expression
Saleem, M. A., O’Hare, M. J., Reiser, J., Coward, R. J., Inward, C. D., Farren, T., Xing, C. Y., Ni, L., Mathieson, P. W., & Mundel, P. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133630 · Cited by 1,120
Self-citation(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60946-x · Cited by 1,071
Rak, J. W., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., & Kerbel, R. S. (1995) · PubMed · Cited by 762
Vascular endothelial growth factor enhances atherosclerotic plaque progression
Celletti, F. L., Waugh, J. M., Amabile, P. G., Brendolan, A., Hilfiker, P. R., & Dake, M. D. (2001) · Nature Medicine · doi:10.1038/86490 · Cited by 708
Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., & Alitalo, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37365-9 · Cited by 694
Alternative splicing: multiple control mechanisms and involvement in human disease
Cáceres, J. F., & Kornblihtt, A. R. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(01)02626-9 · Cited by 652
The dynamics of a pre-mRNA splicing factor in living cells
Misteli, T., Cáceres, J. F., & Spector, D. L. (1997) · Nature · doi:10.1038/387523a0 · Cited by 619
Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation
Mukhopadhyay, D., Tsiokas, L., Zhou, X.-M., Foster, D., Brugge, J. S., & Sukhatme, V. P. (1995) · Nature · doi:10.1038/375577a0 · Cited by 595
(2002) · PubMed · Cited by 550
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451
Self-citationVEGF gene therapy: stimulating angiogenesis or angioma-genesis?
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/80430 · Cited by 370
Li, J., Perrella, M. A., Tsai, J.-C., Yet, S.-F., Hsieh, C.-M., Yoshizumi, M., Patterson, C., Endege, W. O., Zhou, F., & Lee, M.-E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.308 · Cited by 346
van der Houven van Oordt, W., Diaz-Meco, M. T., Lozano, J., Krainer, A. R., Moscat, J., & Cáceres, J. F. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.2.307 · Cited by 345
Coupling of Transcription with Alternative Splicing
Cramer, P., Cáceres, J. F., Cazalla, D., Kadener, S., Muro, A. F., Baralle, F. E., & Kornblihtt, A. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80372-x · Cited by 310
Unbalanced alternative splicing and its significance in cancer
Venables, J. P. (2006) · BioEssays · doi:10.1002/bies.20390 · Cited by 299
Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT
Blaustein, M., Pelisch, F., Tanos, T., Muñoz, M. J., Wengier, D., Quadrana, L., Sanford, J. R., Muschietti, J. P., Kornblihtt, A. R., Cáceres, J. F., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1020 · Cited by 246
Phosphorylated RNA polymerase II stimulates pre-mRNA splicing
Hirose, Y., Tacke, R., & Manley, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.10.1234 · Cited by 240
Promoter usage and alternative splicing
Kornblihtt, A. R. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.04.014 · Cited by 236
Prasad, J., Colwill, K., Pawson, T., & Manley, J. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6991 · Cited by 235
Varey, A. H. R., Rennel, E. S., Qiu, Y., Bevan, H. S., Perrin, R. M., Raffy, S., Dixon, A. R., Paraskeva, C., Zaccheo, O., Hassan, A. B., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604308 · Cited by 226
Self-citationGoad, D. L. (1996) · Endocrinology · doi:10.1210/en.137.6.2262 · Cited by 217
Perrin, R. M., Konopatskaya, O., Qiu, Y., Harper, S., Bates, D. O., & Churchill, A. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1951-8 · Cited by 217
Self-citationFinkenzeller, G., Sparacio, A., Technau, A., Marmé, D., & Siemeister, G. (1997) · Oncogene · doi:10.1038/sj.onc.1201219 · Cited by 201
Cébe Suarez, S., Pieren, M., Cariolato, L., Arn, S., Hoffmann, U., Bogucki, A., Manlius, C., Wood, J., & Ballmer-Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6254-9 · Cited by 198
Alterations of pre‐mRNA splicing in cancer
Kalnin̨a, Z., Zayakin, P., Silin̨a, K., & Linē, A. (2005) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20156 · Cited by 196
Dowhan, D. H., Hong, E. P., Auboeuf, D., Dennis, A. P., Wilson, M. M., Berget, S. M., & O'Malley, B. W. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.025 · Cited by 193
Patterson, C., Perrella, M. A., Endege, W. O., Yoshizumi, M., Lee, M. E., & Haber, E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118816 · Cited by 169
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
Neufeld, G., Cohen, T., Gitay-Goren, H., Poltorak, Z., Tessler, S., Sharon, R., Gengrinovitch, S., & Levi, B.-Z. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437467 · Cited by 165
Common themes in the function of transcription and splicing enhancers
Hertel, K. J., Lynch, K. W., & Maniatis, T. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80007-5 · Cited by 143
Bakin, A. V., Safina, A. F., Rinehart, C., Daroqui, C., Darbary, H. K., & Helfman, D. M. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-04-0353 · Cited by 143
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
Pritchard‐Jones, R., Dunn, D., Qiu, Y., Varey, A. H. R., Orlando, A., Rigby, H., Harper, S. J., & Bates, D. O. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603839 · Cited by 133
Self-citationThe endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
Rennel, E. S., Waine, E., Guan, H., Schüler, Y., Leenders, W. P. J., Woolard, J., Sugiono, M., Gillatt, D. A., Kleinerman, E. S., Bates, D. O., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604309 · Cited by 131
Self-citationSone, H., Kawakami, Y., Okuda, Y., Kondo, S., Hanatani, M., Suzuki, H., & Yamashita, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0568 · Cited by 118
Cell stress modulates the function of splicing regulatory protein RBM4 in translation control
Lin, J.-C., Hsu, M., & Tarn, W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611015104 · Cited by 105
Conditioned Medium from Mouse Sarcoma 180 Cells Contains Vascular Endothelial Growth Factor
Rosenthal, R. A., Megyesi, J. F., Henzel, W. J., Ferrara, N., & Folkman, J. (1990) · Growth Factors · doi:10.3109/08977199009011010 · Cited by 100
Antiangiogenesis drug promising for metastatic colorectal cancer
McCarthy, M. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13603-3 · Cited by 94
Cui, T.-G., Foster, R. R., Saleem, M. A., Mathieson, P. W., Gillatt, D. A., Bates, D. O., & Harper, S. J. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00337.2003 · Cited by 91
Self-citationJones, D. S., MacPherson, A. M., Archer, D. F., Leslie, S., Makkink, W. K., Sharkey, A., & Smith, S. K. (2000) · Human Reproduction · doi:10.1093/humrep/15.suppl_3.85 · Cited by 85
Recombinant human VEGF165b protein is an effective anti-cancer agent in mice
Rennel, E., Hamdollah‐Zadeh, M., Wheatley, E. R., Magnussen, A., Schüler, Y., Kelly, S., Finucane, C. M., Ellison, D. H., Suarez, S., Ballmer‐Hofer, K., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.05.027 · Cited by 80
Self-citationImpaired Glomerular Maturation and Lack of VEGF165b in Denys-Drash Syndrome
Schumacher, V., Jeruschke, S., Eitner, F., Becker, J. U., Pitschke, G., Ince, Y., Miner, J. H., Leuschner, I., Engers, R., Everding, A. S., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006020124 · Cited by 74
Bates, D. O., Macmillan, P., Manjaly, J., Qiu, Y., Hudson, S. J., Bevan, H. S., Hunter, A. J., SOOTHILL, P. W., Read, M., Donaldson, L. F., et al. (2006) · Clinical Science · doi:10.1042/cs20050292 · Cited by 69
Self-citationAlternative Splicing— When Two’s a Crowd
Smith, C. W. J. (2005) · Cell · doi:10.1016/j.cell.2005.09.010 · Cited by 68
Keck, R. G., Berleau, L. T., Harris, R. J., & Keyt, B. A. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0145 · Cited by 68
Koenigsberger, C., Chicca, J. J., Amoureux, M., Edelman, G. M., & Jones, F. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050578797 · Cited by 67
Qiu, Y., Bevan, H. S., Weeraperuma, S., Wratting, D., Murphy, D., Neal, C. R., Bates, D. O., & Harper, S. J. (2007) · The FASEB Journal · doi:10.1096/fj.07-9718com · Cited by 59
Self-citationLechuga, C. G., Nazará, Z., Rosales, J.-A. D., Morris, E. R., Rincón‐Sánchez, A. R., Rivas, A., Esteban-Gamboa, A., & Rojkind, M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00264.2003 · Cited by 54
Matsumoto, K., Ohi, H., & Kanmatsuse, K. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000190275 · Cited by 43
Cohen, C. D., Doran, P., Blattner, S. M., Merkle, M., Wang, G. Q., Schmid, H., Mathieson, P. W., Saleem, M. A., Henger, A., Rastaldi, M. P., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020204 · Cited by 27
Self-citationKOTSUJI, T., Imakado, S., Kawachi, Y., & Otsuka, F. (2002) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2002.tb00208.x · Cited by 19
Li, H., Yonekura, H., Kim, C., Sakurai, S., Yamamoto, Y., Takiya, T., Futo, S., Watanabe, T., & Yamamoto, H. (2004) · Endothelium · doi:10.1080/10623320490904250 · Cited by 10
Cited by
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
Hallmarks of alternative splicing in cancer
Oltean, S., & Bates, D. O. (2014) · Oncogene · doi:10.1038/onc.2013.533 · Cited by 664
Self-citationVEGF-A splicing: the key to anti-angiogenic therapeutics?
Harper, S. J., & Bates, D. O. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2505 · Cited by 514
Self-citationMolecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Peach, C. J., Mignone, V. W., Arruda, M. A., Alcobia, D. C., Hill, S. J., Kilpatrick, L. E., & Woolard, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041264 · Cited by 512
Self-citationLee, C., Kim, M.-J., Kumar, A., Lee, H.-W., Yang, Y., & Kim, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02249-0 · Cited by 365
Metadata
- Authors
- Nowak, D. G., Woolard, J., Amin, E. M., Konopatskaya, O., Saleem, M. A., Churchill, A. J., Ladomery, M. R., Harper, S. J., & Bates, D. O.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2008-10-15
- Volume
- 121
- Issue
- 20
- Pages
- 3487-3495
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W1992049575
- Cited by
- 339
- References
- 60
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.